Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $12.96M | $6.49M | $46.53M | $11.40M | $13.12M |
| Selling and Admin Expenses | $6.38M | $4.55M | $22.20M | $4.66M | $6.37M |
| Research & Development | $6.58M | $1.94M | $24.32M | $6.75M | $6.75M |
| Operating Profit | -$12.96M | -$6.49M | -$46.53M | -$11.40M | -$13.12M |
| Net Non-Operating Interest Income (Expense) | $0.00 | -$37,000.00 | -$4.61M | $0.00 | $0.00 |
| Non-Operating Interest Expense | $0.00 | $37,000.00 | $4.61M | $0.00 | $0.00 |
| Other Income (Expense) | $1.62M | -$2.05M | -$22.71M | $833,000.00 | $252,000.00 |
| Gain on Sale of Security | $4.45M | -$106,000.00 | -$2.23M | – | – |
| Other Non-Operating Income (Expenses) | -$2.83M | -$1.94M | -$3.42M | $833,000.00 | $252,000.00 |
| Pretax Profit | -$11.34M | -$8.58M | -$73.85M | -$10.57M | -$12.87M |
| Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Profit | -$11.34M | -$8.58M | -$73.85M | -$10.57M | -$12.87M |
| Profit from Continuing Operations | -$11.34M | -$8.58M | -$73.85M | -$10.57M | -$12.87M |
| Net Income to Parent Company | -$11.34M | -$8.58M | -$73.85M | -$10.57M | -$12.87M |
| Net Income to Common Stockholders | -$11.34M | -$8.58M | -$73.85M | -$10.57M | -$12.87M |
| Basic EPS | -$0.61 | -$0.08 | -$0.69 | -$0.10 | -$0.12 |
| Diluted EPS | -$0.85 | -$0.08 | -$0.69 | -$0.10 | -$0.12 |
| Special Income (Charges) | – | – | -$17.06M | – | – |
| -Less:Impairment of Capital Assets | – | – | $17.06M | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL | 2017 ANNUAL |
|---|---|---|---|---|---|
| Total Assets | $142.65M | $62.39M | $62.78M | $116.03M | $395.86M |
| Total Current Assets | $115.60M | $34.00M | $32.89M | $49.64M | – |
| Cash and Cash Equivalents & Short-Term Investments | $112.83M | $25.45M | $28.89M | $48.25M | $115.48M |
| -Cash and Cash Equivalents | $112.83M | $25.45M | $28.89M | $48.25M | $115.48M |
| Receivables | $103,000.00 | $3.36M | $1.15M | $589,000.00 | $69.62M |
| -Other Receivables | $103,000.00 | $3.36M | $1.15M | $589,000.00 | – |
| Current Deferred Assets | $0.00 | $3.47M | $1.42M | $0.00 | – |
| Other Current Assets | $2.67M | $1.72M | $1.43M | $797,000.00 | – |
| Total Non-Current Assets | $27.05M | $28.40M | $29.89M | $66.40M | – |
| Net PPE | $26.17M | $27.47M | $28.85M | $63.23M | $2.89M |
| -Gross PPE | $39.61M | $40.88M | $41.65M | $78.08M | – |
| -Accumulated Depreciation | -$13.45M | -$13.41M | -$12.80M | -$14.86M | – |
| Other Non-Current Assets | $886,000.00 | $924,000.00 | $1.04M | $3.17M | – |
| Total Liabilities | $57.66M | $291.03M | $284.18M | $272.53M | $331.10M |
| Total Current Liabilities | $6.60M | $6.19M | $5.08M | $4.42M | – |
| Payables | $720,000.00 | $656,000.00 | $741,000.00 | $472,000.00 | – |
| -Accounts Payable | $720,000.00 | $656,000.00 | $741,000.00 | $472,000.00 | – |
| Current Accrued Expenses | $3.29M | $3.29M | $2.22M | $957,000.00 | $5.98M |
| Short-Term Debt and Capital Lease Obligation | $1.45M | $1.40M | $1.36M | $1.92M | – |
| -Current Capital Lease Obligation | $1.45M | $1.40M | $1.36M | $1.92M | – |
| Total Non-Current Liabilities | $51.06M | $284.85M | $279.10M | $268.11M | – |
| Long Term Debt and Capital Lease Obligation | $6.44M | $31.71M | $26.07M | $17.31M | $70.15M |
| -Long Term Capital Lease Obligation | $6.44M | $6.82M | $7.18M | $17.31M | – |
| Derivative Product Liabilities | $44.62M | $3.48M | $3.38M | $1.15M | – |
| Convertible preferred securities | $0.00 | $249.65M | $249.65M | $249.65M | – |
| Total Equity | $85.00M | -$228.64M | -$221.39M | -$156.50M | $64.76M |
| Stockholders' Equity | $85.00M | -$228.64M | -$221.39M | -$156.50M | $64.76M |
| Capital Stock | $11,000.00 | $0.00 | $0.00 | $0.00 | $413,000.00 |
| -Common Stock | $11,000.00 | $0.00 | $0.00 | $0.00 | $413,000.00 |
| Additional Paid-In Capital | $361.30M | $36.29M | $34.66M | $25.19M | $458.12M |
| Retained Earnings | -$275.49M | -$264.15M | -$255.58M | -$181.73M | -$395.68M |
| Gains/Losses Not Affecting Retained Earnings | -$819,000.00 | -$743,000.00 | -$445,000.00 | $76,000.00 | $1.90M |
| -Long Term Debt | – | $24.90M | $18.89M | – | $70.15M |
| Less: Treasury Stock | – | $34,000.00 | $34,000.00 | $34,000.00 | – |
| -Accounts Receivable | – | – | – | – | $69.62M |
| Investments and Advances | – | – | – | – | $129.95M |
| Goodwill and Other Intangible Assets | – | – | – | – | $36.24M |
| -Goodwill | – | – | – | – | $29.38M |
| -Other Intangible Assets | – | – | – | – | $6.86M |
| -Preferred Stock | – | – | – | – | $0.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$5.27M | -$6.12M | -$30.16M | -$6.99M | -$6.10M |
| Net cash flow from continuing operations | -$5.27M | -$6.12M | -$30.16M | -$6.99M | -$6.10M |
| Net Income from Continuing Operations | -$11.34M | -$8.58M | -$73.85M | -$10.57M | -$12.87M |
| Gain/Loss from Continuing Operations | $417,000.00 | $602,000.00 | $2.30M | -$681,000.00 | $58,000.00 |
| Depreciation & Depletion & Amortization | $920,000.00 | $882,000.00 | $6.73M | $2.19M | $2.19M |
| Other Non-Cash Items | -$4.42M | $310,000.00 | $5.90M | $327,000.00 | $341,000.00 |
| Change in Working Capital | $4.81M | -$2.62M | -$2.16M | -$5,000.00 | $320,000.00 |
| -Change in Receivables | $3.26M | -$2.21M | -$563,000.00 | -$96,000.00 | $545,000.00 |
| -Change in Prepaid Assets | -$956,000.00 | -$306,000.00 | -$625,000.00 | -$33,000.00 | $70,000.00 |
| -Change in Payables and Accrued Expense | $2.80M | $97,000.00 | $404,000.00 | $416,000.00 | $3,000.00 |
| -Change in Other Current Assets | $40,000.00 | $120,000.00 | -$160,000.00 | $0.00 | $0.00 |
| -Change in Other Current Liabilities | -$333,000.00 | -$320,000.00 | -$1.21M | -$292,000.00 | -$298,000.00 |
| Net cash flow from investing | -$91,000.00 | -$487,000.00 | $1.33M | -$13,000.00 | -$172,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$91,000.00 | -$487,000.00 | $1.33M | -$13,000.00 | -$172,000.00 |
| Net PPE Purchase and Sale | -$91,000.00 | -$487,000.00 | $1.33M | -$13,000.00 | -$172,000.00 |
| Financing Cash Flow | $92.79M | $3.30M | $7.30M | -$203,000.00 | -$205,000.00 |
| Net Cash Flow from Continuing Financing Activities | $92.79M | $3.30M | $7.30M | -$203,000.00 | -$205,000.00 |
| Net Issuance Payments Of Debt | $1.04M | $4.30M | $7.39M | -$207,000.00 | -$207,000.00 |
| Proceeds from Stock Option Exercised | $0.00 | $90,000.00 | $19,000.00 | $4,000.00 | $2,000.00 |
| Net Other Financing Charges | $91.75M | -$1.09M | -$108,000.00 | – | – |
| Ending Cash Balance | $113.72M | $26.33M | $29.77M | $37.74M | $44.91M |
| Net Change in Cash | $87.43M | -$3.31M | -$21.54M | -$7.20M | -$6.48M |
| Beginning Cash Balance | $26.33M | $29.77M | $51.42M | $44.91M | $51.42M |
| Effect of Exchange Rate Changes | -$43,000.00 | -$134,000.00 | -$113,000.00 | $32,000.00 | -$36,000.00 |
| Free Cash Flow | -$5.36M | -$6.61M | -$31.26M | -$7.00M | -$6.28M |
No comments yet — be the first to weigh in on FAC.